APA (7th ed.) Citation

UE, B., A, S., V, J., WZ, W., F, C., BP, K., & WS, W. (2012). IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells. Cancer immunology, immunotherapy : CII, 61(9), 1473. https://doi.org/10.1007/s00262-012-1215-7

Chicago Style (17th ed.) Citation

UE, Burkhardt, Sloots A, Jakobi V, Wei WZ, Cavallo F, Kloke BP, and Wels WS. "IL-15 Augments Antitumoral Activity of an ErbB2/HER2 Cancer Vaccine Targeted to Professional Antigen-presenting Cells." Cancer Immunology, Immunotherapy : CII 61, no. 9 (2012): 1473. https://doi.org/10.1007/s00262-012-1215-7.

MLA (9th ed.) Citation

UE, Burkhardt, et al. "IL-15 Augments Antitumoral Activity of an ErbB2/HER2 Cancer Vaccine Targeted to Professional Antigen-presenting Cells." Cancer Immunology, Immunotherapy : CII, vol. 61, no. 9, 2012, p. 1473, https://doi.org/10.1007/s00262-012-1215-7.